Can Fite Biopharma Ltd (CANF) Directors and Executive Officers

Officers & Directors

Can-Fite Therapeutics' leadership includes Pnina Fishman, Ph.D., Executive Chairman of the Board and Chief Scientific Officer since June 2023. She co-founded the company and served as CEO from 2005 to June 2023. Dr. Fishman previously was a professor and laboratory head at the Felsenstein Medical Research Institute and has authored over 150 publications. She has managerial experience as CEO of Mor Research Application and serves on the boards of F.D Consulting Ltd., Eye-Fite Ltd., and Ultratrend. She holds a Ph.D. in Immunology from Bar Ilan University. Motti Farbstein is the Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer. He joined Can-Fite in 2003, served as COO from 2003 to 2005, then as COO and CFO, and became CEO in June 2023. He has been a director of Eye-Fite Ltd. since 2011 and has seven years of experience as Vice President of Mor Research Application, with expertise in clinical trial data management. Sari Fishman, Ph.D., serves as Vice President of Business Development. She was Director of Clinical Affairs from 2004 to 2014, Director of Business Development from 2014 to 2017, and has been Vice President since 2017. She earned her Ph.D. at Bar-Ilan University and is the daughter of Pnina Fishman. The board of directors includes Abraham Sartani, M.D., a director since 2001 with over 30 years in the pharmaceutical industry. He has held positions including Vice President of R&D and Licensing at Recordati (1985–2008) and Medical Director for Europe at Farmitalia-Carlo Erba (1980–1985). He has served on the board of Akkadeas Pharma Srl and currently serves on the board of BLV Pharma Group Srl. Dr. Sartani is a consultant, member of scientific societies, and author of publications and patents. Guy Regev has been a director since 2011 and a member of the Audit and Compensation Committees since 2014. He is CEO of Gaon Holdings Ltd. and has over 14 years of experience in accounting, financial management, and general management. He is also a director of OphthaliX since 2011.

Can fite Biopharma Ltd currently has 5 employees.